Author Question: Tulugaq, an Inuit, experiences dissociative-like episodes that are accompanied by extreme ... (Read 61 times)

asd123

  • Hero Member
  • *****
  • Posts: 557
Tulugaq, an Inuit, experiences dissociative-like episodes that are accompanied by extreme excitement. He often performs aggressive and dangerous acts, although he does not remember them. One of his recent episodes was followed by convulsions and he went into a coma for two days. Tulugaq suffers from ____.
 
  a. zar
 b. brain fag
  c. piblokto
 d. dhat

Question 2

Which statement about somatic symptom disorder is accurate?
 
  a. It is a form of dissociative disorder.
 b. It is rarely associated with anxiety, depression, or other psychiatric disorders.
 c. It is relatively rare, having a prevalence of 2 percent for women and 0.2 percent for men.
  d. It is more prevalent among educated individuals than among uneducated ones.



peter

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

c

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library